Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

scientific article

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.LUNGCAN.2008.06.003
P698PubMed publication ID18620780
P5875ResearchGate publication ID5231354

P50authorJanne LehtiöQ37384646
Maria PernemalmQ50285787
Hirsh KoyiQ57305125
Lukas M OrreQ81444732
Rolf LewensohnQ114420426
Lena KanterQ116997587
P2093author name stringLuigi De Petris
P433issue3
P921main subjectlung cancerQ47912
P304page(s)410-417
P577publication date2008-07-11
P1433published inLung CancerQ641464
P1476titleTumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer
P478volume63

Reverse relations

cites work (P2860)
Q90288697A comprehensive pipeline for translational top-down proteomics from a single blood draw
Q28385552A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma
Q38258912Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation.
Q38478863Changes in protein expression in rat bronchoalveolar lavage fluid after exposure to zinc oxide nanoparticles: an iTRAQ proteomic approach.
Q41421784Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages
Q44086437Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma
Q55495092Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer.
Q51596002Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Q39202347Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel
Q37697035Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.
Q34361505Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Q44892815High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer
Q28743151Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ
Q53081345Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
Q35389059Lung cancer proteomics: recent advances in biomarker discovery
Q34350615Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery
Q34109148Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer
Q35038432Osteopontin is a prognostic biomarker in non-small cell lung cancer
Q50543875Prognostic impact of S100A9 overexpression in non-small cell lung cancer.
Q37730532Progress in Top-Down Proteomics and the Analysis of Proteoforms
Q38100750Proteomic biomarkers in lung cancer
Q37650123S100 protein family in human cancer
Q24294804S100A4 interacts with p53 in the nucleus and promotes p53 degradation
Q34033456S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.
Q38748164S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
Q33514817Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients
Q33720233Systems biology approaches to develop innovative strategies for lung cancer therapy
Q50551664The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence.
Q43678811Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.

Search more.